Bibliography

Found 1068 results

Journal Article

Walker RH, Morgello S, Davidoff-Feldman B, Melnick A, Walsh MJ, Shashidharan P, Brin MF. Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions. Neurology [Internet]. 2002 ;58(7):1031-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11940688

Rottnek M, DiRocco A, Laudier D, Morgello S. Axonal damage is a late component of vacuolar myelopathy. Neurology [Internet]. 2002 ;58(3):479-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11839857

Stern AL, Ghura S, Gannon PJ, Akay-Espinoza C, Phan JM, Yee AC, Vassar R, Gelman BB, Kolson DL, Jordan-Sciutto KL. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism. J Neurosci. 2018 ;38(18):4288-4300.

Dever SM, Rodriguez M, El-Hage N. B-Adrenergic receptor gene expression in HIV-associate neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. Journal of Neurovirology. 2016 .

Woods SPaul, Conover E, Weinborn M, Rippeth JD, Brill RM, Heaton RK, Grant I, HNRC. Base rate of Hiscock Digit Memory Test failure in HIV-associated neurocognitive disorders. The Clinical Neuropsychologist [Internet]. 2003 ;17(3):383-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14704888

Woods SPaul, Childers ME, Ellis RJ, Guaman S, Grant I, Heaton RK. A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2006 ;21(1):83-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16169705

Saloner R, Grelotti DJ, Tyree G, Sundermann EE, Ma Q, Letendre S, Heaton RK, Cherner M. Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2019 ;82(5):475-482.

Fields JAdam, Swinton MK, Soontornniyomkij B, Carson A, Achim CL. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS. 2020 ;34(7):1001-1007.

Anderson AM, Pérez-Santiago J, Zheng Z, Huang E, Franklin D, Iudicello J, Moore DJ, Ellis RJ, Heaton RK, Letendre SL. Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 ;33(15):2309-2316.

Shapshak P, Duncan R, Turchan-Cholewo J, Nath A, Minagar A, Kangueane P, Davis W, Chiappelli F, Elkomy FF, Seth R, et al. Bioinformatics models in drug abuse and Neuro-AIDS: Using and developing databases. Bioinformation [Internet]. 2006 ;1(3):86-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17597862

Shapshak P. Bioinformation and molecule of the month: Multiple interactive pathways for a single gene, NFkB. Bioinformation. 2012 ;8(9):399-402.

Shapshak P. Bioinformation editorial erratum. Bioinformation. 2013 ;9(3):168.

Wiederin J, Rozek W, Duan F, Ciborowski P. Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Science [Internet]. 2009 ;7:8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19292902

Ciborowski P. Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches. Biomark Med [Internet]. 2009 ;3:771-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=%20%20%20%2020477714

Joseph SB, Gianella S, Burdo TH, Cinque P, Gisslén M, Letendre S, Nath A, Morgello S, Ndhlovu LC, Spudich S. Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology. J Infect Dis. 2023 ;227(Suppl 1):S3-S15.

Sun B, Dalvi P, Abadjian L, Tang N, Pulliam L. Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV. AIDS. 2017 ;31(14):F9-F17.

Bertrand L, Cho HJoon, Toborek M. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain. 2019 ;142(3):502-511.

Gelman B, Schuenke KW. Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. Journal of NeuroVirology [Internet]. 2004 ;10(2):98-108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15204928

Solomon IH, De Girolami U, Chettimada S, Misra V, Singer EJ, Gabuzda D. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis. 2017 ;17(1):151.

Gutierrez J, Honig L, Elkind MSV, Mohr JP, Goldman JE, Dwork AJ, Morgello S, Marshall RS. Brain arterial aging and its relationship to Alzheimer Dementia. Neurology. 2016 ;86(16):1507-1515.

Gutierrez J, Honig L, Elkind MSV, Mohr JP, Goldman J, Dwork AJ, Morgello S, Marshall RS. Brain arterial aging and its relationship to Alzheimer dementia. Neurology. 2016 ;86(16):1507-15.

Gutierrez J, Goldman J, Dwork AJ, Elkind MSV, Marshall RS, Morgello S. Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. Neurology. 2015 ;85(13):1139-45.

Green DA, Masliah E, Vinters HV, Beizai P, Moore D, Achim C. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (London, England) [Internet]. 2005 ;19(4):407-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15750394

Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr HIV Res. 2014 ;12(2):97-110.

Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Current HIV Research [Internet]. 2014 ;12(2):97-110. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24862332

Pages